









Markets
/
Stocks
/
nasdaq-airs
/

Airsculpt Technologies Inc

AIRS

6.150USD

-0.040-0.65%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

383.99MMarket Cap

LossP/E TTM



Airsculpt Technologies Inc

6.150

-0.040-0.65%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

49 / 72

Overall Ranking

243 / 4721

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Hold

Current Rating

6.000

Target Price

-3.07%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). Its direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

Fairly Valued

The company’s latest PE is -24.57, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 60.76M shares, increasing 0.80% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 706.25K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 2.45.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 6.40, which is lower than the Healthcare Providers & Services industry's average of 7.42. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 44.01M, representing a year-over-year decrease of 13.71%, while its net profit experienced a year-over-year decrease of 81.57%.

Score

Industry at a Glance

Previous score

6.40

Change



Financials

5.75

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.92

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.67

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.18

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 1.20, which is lower than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is -24.73, which is -23.90% below the recent high of -18.82 and -70.33% above the recent low of -42.12.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 49/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 6.50, which is lower than the Healthcare Providers & Services industry's average of 7.58. The average price target for Airsculpt Technologies Inc is 6.00, with a high of 7.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

6.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Hold

Current Rating

6.000

Target Price

-3.07%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

AirSculpt Technologies Inc

AIRS

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 6.97, which is higher than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 6.86 and the support level at 5.57, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.97

Change

-0.05

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.067

Neutral

RSI(14)

50.088

Neutral

STOCH(KDJ)(9,3,3)

58.957

Buy

ATR(14)

0.413

Low Volatility

CCI(14)

9.736

Neutral

Williams %R

50.404

Neutral

TRIX(12,20)

-0.147

Sell

StochRSI(14)

92.272

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

6.036

Buy

MA10

6.087

Buy

MA20

6.199

Sell

MA50

6.126

Buy

MA100

5.151

Buy

MA200

4.760

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 97.31%, representing a quarter-over-quarter increase of 0.05%. The largest institutional shareholder is The Vanguard, holding a total of 706.25K shares, representing 1.13% of shares outstanding, with 7.24% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Vesey Street Capital Partners, L.L.C.

29.32M

Rollins (Aaron)

14.72M

+0.01%

Thrivent Asset Management, LLC

5.17M

SW Investment Management LLC

4.70M

Balyasny Asset Management LP

487.53K

+17.22%

BlackRock Institutional Trust Company, N.A.

757.58K

-1.76%

The Vanguard Group, Inc.

Star Investors

601.28K

-1.51%

Dean (Dennis R)

620.66K

+79.08%

Jashnani (Yogesh)

464.88K

+1.53%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.01, which is lower than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 2.48. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.